Pharmaceutical Management Agency

Under 40s - extent of co-prescribing for ADHD, anxiety, depression.

Response by Pharmaceutical Management Agency to J Bruning on October 30, 2024.

Partially successful.

Kia ora Jodie, Please find attached a response to your Official Information Act request, which was received on 2 October 2024. Please cont...

Homonal treatment data

Response by Pharmaceutical Management Agency to Simon Tegg on May 31, 2024.

Successful.

Kia ora, Please find attached a response to your Official Information Act request of 5 May 2024. Thank you Government Services - Pharmac 31 May 2024...

GnRH Agonist statistics

Response by Pharmaceutical Management Agency to Simon Tegg on March 01, 2024.

Successful.

Kia ora Simon Please find a response to your request attached to this email. Ngâ mihi, Katy Carlson (she/her) | Government Services Advisor _______...

Meeting with New Minister

Response by Pharmaceutical Management Agency to T Murray on January 26, 2024.

Successful.

Kia ora T Murray Please find a response to your request attached to this email. Ngâ mihi, Katy Carlson (she/her) | Government Services Advisor ____...

Maori staff retention

Response by Pharmaceutical Management Agency to TR on June 16, 2023.

Successful.

Tçnâ koe Please find a response to your request for information attached. Ngâ mihi, nâ Melody Willis (she/her) | Government Services Advisor ______...

Estimating the number of people prescribed PrEP

Response by Pharmaceutical Management Agency to Bianca Sepulveda on June 11, 2021.

Successful.

Kia ora Bianca Please find attached a response to your recent request for information. Ngā mihi Melody Willis ([1]she/her) | Gove...

Trikafta Funding Announcement

Response by Pharmaceutical Management Agency to Phillip Hart on February 21, 2023.

Partially successful.

Tçnâ koe Phillip Further to our previous communications, we have now published [1]information about our communications approach for the Trikafta...

Correspondence between Pharmac and Draper Cormack re 2022-23-125; A1665003

Response by Pharmaceutical Management Agency to Harris Leigh on April 28, 2023.

Successful.

Tēnā koe Harris Please find a response to your request for information attached with this email. Ngā mihi, nā Melody Willis ([1]...

Procurement process for Cormack Draper

Response by Pharmaceutical Management Agency to Harris Leigh on March 28, 2023.

Partially successful.

Tçnâ koe Harris Please find a response to your below request for information attached to this email. Ngâ mihi, nâ Melody Willis...

Rolling reviews of safety & efficacy of (non-mRNA gene therapy) COVID-19 treatments

Response by Pharmaceutical Management Agency to J Bruning on January 17, 2023.

Successful.

Kia ora Please find a response to your request for information attached with this email. Ngā mihi Melody Willis (she/her) | Government Services Adv...

Process and progress of approval for pediatric/under 5’s covid vaccines

Response by Pharmaceutical Management Agency to Scout Barbour-Evans on September 20, 2022.

Partially successful.

Kia ora Scout Please find attached a response to your request for official information. Ngā mihi OIA Services Team M[1]inistry of Health...

Ordering Moderna's Bivalent vaccine

Response by Pharmaceutical Management Agency to Athina Andonatou on October 13, 2022.

Successful.

Hi Athina, Please find a response to your request attached to this email. Kind regards, Gendi 13 October 2022 Athina Andonatou Via email: [FOI #205...

Molnupiravir for Horses, Zebras & Donkeys - offspring born with no teeth & skull missing

Response by Pharmaceutical Management Agency to Micky Turner on January 24, 2022.

Successful.

Thank you for emailing Pharmac enquiries. * [1]View a list of all currently funded medicines (the Pharmaceutical Schedule) * [2]View the progress o...

COVID-19 Early Treatment Options - where are they?

Response by Pharmaceutical Management Agency to Micky Turner on January 17, 2022.

Successful.

Tēnā koe Micky Pharmac is continuing to evaluate potential treatments for COVID-19 as evidence emerges. We are happy to consider funding a...

Remdesivir costs $4400 per person - Covid 19: European study finds no clinical benefit

Request to Pharmaceutical Management Agency by Micky Turner. Annotated by Virginia Crawford on December 17, 2021.

Successful.

According to the reply to a recent OIA request, 25 people were treated with Remdesivir in Auckland during the recent outbreak (there may be more since...

Why have you restricted Ivermectin?

Response by Pharmaceutical Management Agency to Annie Weston on September 20, 2021.

Successful.

Mōrena Annie Please find attached a response to your further correspondence regarding ivermectin. Ngā mihi Melody Willis (she/her) | Government Ser...

Information regarding Dexcom CGMS and Libre FGMS

Response by Pharmaceutical Management Agency to D Smith on March 26, 2021.

Awaiting classification.

Kia ora D Smith Further to our previous email to you on Friday 19 March 2021, please find attached the final response to your request for inform...

Cost of PreP since funding began in 2018

Response by Pharmaceutical Management Agency to Elliot Ikilei on February 05, 2021.

Successful.

Kia ora Elliot Please find attached a response to your request for information received by PHARMAC on 6 January 2021. Please feel free to...

Cost of funding Tramadol in 2019

Response by Pharmaceutical Management Agency to Brianna Stewart on September 03, 2020.

Successful.

Kia ora Brianna Please find the response to your OIA 2020-21-020 dated 18 August 2020 regarding tramadol funding for calendar year 2019. N...

PTAC subcommittees- OIA request

Response by Pharmaceutical Management Agency to john luke on August 10, 2020.

Successful.

Kia ora John Please find attached to this email a response to your OIA request 2020-21-015 dated 14 July 2020. Ngā mihi Melody W...

Discontinuation of Phenelzine Sulphare

Response by Pharmaceutical Management Agency to Megs on June 19, 2020.

Successful.

Dear Megs Attached is PHARMAC's response to your recent information request. Kind regards PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9,...

Rationale for defunding of Androderm 2.5mg Patches

Response by Pharmaceutical Management Agency to Scout Barbour-Evans on June 11, 2019.

Successful.

Hello Scout Androderm 2.5mg patches were delisted from the Pharmaceutical Schedule from 1 March 2018. In October 2016, the manufacturers proposed del...

Consumer Advisory Committee (CAC)

Response by Pharmaceutical Management Agency to john luke on April 23, 2020.

Successful.

Good afternoon John Please find attached PHARMAC's response to your recent request for information about CAC membership. Kind regards, Susan Susan...

Shortage of Phenelzine sulphate

Response by Pharmaceutical Management Agency to Megs on October 14, 2019.

Successful.

Dear Megs Please find attached a letter and related documents related to your request for information about phenelzine supply. Kind regards Simon E...

Citation list for PHARMAC funded thyroid medications and patient survey data

Response by Pharmaceutical Management Agency to Belinda Hodson on February 24, 2020.

Partially successful.

Dear Belinda Please find attached further correspondence in relation to your request for information about thyroid medications (OIA reference 2019-20-...

FYI

More about this authority